These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26468002)

  • 1. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
    Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
    Heinze G; Hronsky M; Reichardt B; Baumgärtel C; Müllner M; Bucsics A; Winkelmayer WC
    Appl Health Econ Health Policy; 2015 Apr; 13(2):193-205. PubMed ID: 25536928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of drug usage and expenditure in a hospital diabetes clinic.
    Wu SY; Lung BC; Chang S; Lee SC; Critchley JA; Chan JC
    J Clin Pharm Ther; 1998 Feb; 23(1):49-56. PubMed ID: 9756112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
    Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study.
    Tian Y; Reichardt B; Dunkler D; Hronsky M; Winkelmayer WC; Bucsics A; Strohmaier S; Heinze G
    Sci Rep; 2020 Apr; 10(1):5964. PubMed ID: 32249786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.
    Raebel MA; Ellis JL; Carroll NM; Bayliss EA; McGinnis B; Schroeder EB; Shetterly S; Xu S; Steiner JF
    J Gen Intern Med; 2012 Jan; 27(1):57-64. PubMed ID: 21879374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
    Lan J; Zhao Y; Dong F; Yan Z; Zheng W; Fan J; Sun G
    J Ethnopharmacol; 2015 Feb; 161():69-81. PubMed ID: 25498346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prestroke treatment of stroke risk factors: A cross-sectional survey in central Nigeria.
    Alkali NH; Bwala SA; Dunga JA; Watila MM; Jibrin YB; Tahir A
    Ann Afr Med; 2016; 15(3):120-5. PubMed ID: 27549416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
    Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
    Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G; Zambon A; Parodi A; Merlino L; Mancia G
    Am J Hypertens; 2012 May; 25(5):549-55. PubMed ID: 22278212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
    Rettig SM; Wood Y; Hirsch JD
    J Am Pharm Assoc (2003); 2013; 53(4):427-31. PubMed ID: 23892818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a value-based formulary in three chronic disease cohorts.
    Yeung K; Basu A; Marcum ZA; Watkins JB; Sullivan SD
    Am J Manag Care; 2017 Mar; 23(3 Suppl):S46-S53. PubMed ID: 29648740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
    Maciejewski ML; Livingston EH; Kahwati LC; Henderson WG; Kavee AL; Arterburn DE
    Surg Obes Relat Dis; 2010; 6(6):601-7. PubMed ID: 20965791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
    Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
    Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.
    Gellad WF; Good CB; Lowe JC; Donohue JM
    Am J Manag Care; 2010 Oct; 16(10):741-50. PubMed ID: 20964470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.